Results 91 to 100 of about 10,048,421 (237)

Core Outcome Measures for Clinical Effectiveness Trials of Nutritional and Metabolic Interventions in Critical Illness: An International Modified Delphi Consensus Study Evaluation (CONCISE) [PDF]

, 2022
Thomas Davies, Rob van Gassel, Marcel C.G. van de Poll, Jan Gunst, Michaël P. Casaer, Kenneth B. Christopher, Jean Charles Preiser, Aileen Hill, Kürşat Gündoğan, Annika Reintam Blaser, Anne‐Françoise Rousseau, Carol Hodgson, Dale M. Needham, Melina Gouveia Castro, Stefan J. Schaller, T. McClelland, Joshua Pilkington, Carla M. Sevin, Paul E. Wischmeyer, Zheng‐Yii Lee, Deepak Govil, Andrew Li, Lee‐anne S. Chapple, Linda Denehy, Juan Carlos Montejo, Beth Taylor, Danielle E. Bear, Rupert M. Pearse, Angela McNelly, John R. Prowle, Zudin Puthucheary   +30 more
openalex   +1 more source

How close is autophagy-targeting therapy for Alzheimer's disease to clinical use? A summary of autophagy modulators in clinical studies

Frontiers in Cell and Developmental Biology
Alzheimer’s disease (AD) is a neurodegenerative disorder clinically characterized by progressive decline of memory and cognitive functions, and it is the leading cause of dementia accounting for 60%–80% of dementia patients. A pathological hallmark of AD
Sofia Miranda Fernandes, Johanna Mayer, Per Nilsson, Makoto Shimozawa   +3 more
doaj   +1 more source

Virtual Clinical Trials: One Step Forward, Two Steps Back [PDF]

, 2017
Virtual clinical trials have entered the medical research landscape. Today’s clinical trials recruit subjects online, obtain informed consent online, send treatments such as medications or devices to the subjects’ homes, and require subjects to record ...
Andrews, Lori, Franco, Alexandra, Kostelecky, Kayla, Spritz, Stephanie   +3 more
core   +1 more source

Traumatic Brain Injury Recovery with Photobiomodulation: Cellular Mechanisms, Clinical Evidence, and Future Potential

Cells
Traumatic Brain Injury (TBI) remains a significant global health challenge, lacking effective pharmacological treatments. This shortcoming is attributed to TBI’s heterogeneous and complex pathophysiology, which includes axonal damage, mitochondrial ...
Lew Lim
doaj   +1 more source

Alzheimer\u27s Disease and Down\u27s Syndrome: An Overview [PDF]

, 2011
The association between Alzheimer\u27s Disease and Down\u27s Syndrome is well recognized through clinical observations and genetic studies. However, the exact nature and the implications of this link is far from clear as yet.
Desai, M.B.B.S., Dr.Devanshu
core   +1 more source

Manejo de la dislipemia aterogénica en Atención Primaria: descripción de la práctica clínica habitual (Estudio Avanza) = Management of Atherogenic Dyslipidemia in Primary Care: description of Routine Clinical Practice (AVANZA Study)

, 2021
Jessica Capón Álvarez
openalex   +1 more source

The impact of photodynamic therapy on immune system in cancer – an update

Frontiers in Immunology
Photodynamic therapy (PDT) is a therapeutic approach that has gained significant attention in recent years with its promising impact on the immune system.
Tomasz Dudzik, Igor Domański, Sebastian Makuch   +2 more
doaj   +1 more source

Clinical Factors on Dental Implant Fractures: A Systematic Review

Dentistry Journal
Dental implant fractures pose a significant challenge to long-term treatment success. This systematic review aims to comprehensively examine the clinical factors influencing dental implant fractures (IFs). Furthermore, strategies to choose the right type
Mattia Manfredini, Pier Paolo Poli, Luca Giboli, Mario Beretta, Carlo Maiorana, Matteo Pellegrini   +5 more
doaj   +1 more source

Targeting signaling pathways in neurodegenerative diseases: Quercetin's cellular and molecular mechanisms for neuroprotection

Animal Models and Experimental Medicine
Background Neurodegenerative diseases (NDs), including Alzheimer‘s disease, Parkinson‘s disease, and Huntington‘s disease, are complex and challenging due to their intricate pathophysiology and limited treatment options.
Md. Rezaul Islam, Md. Ibrahim Khalil Al‐Imran, Mehrukh Zehravi, Sherouk Hussein Sweilam, Mohammad Rakib Mortuza, Jeetendra Kumar Gupta, Thukani Sathanantham Shanmugarajan, Kadirvel Devi, Tanuja Tummala, Mohammed Ali Alshehri, Kalirajan Rajagopal, Mohammed Asiri, Irfan Ahmad, Talha Bin Emran   +13 more
doaj   +1 more source

Editorial: Biomarkers, functional mechanisms, and therapeutic potentials in gastrointestinal cancers

Frontiers in Oncology, 2023
Jun Huang, Qun Zhang, GuangZhao Pan, GuangZhao Pan, Xin Hu, Dongshi Chen, Kui Zhang   +6 more
doaj   +1 more source